| 000 | 01834 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514235801.0 | ||
| 264 | 0 | _c20060411 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a1471-2482 | ||
| 024 | 7 |
_a10.1186/1471-2482-5-18 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLuntz, Steffen P | |
| 245 | 0 | 0 |
_aHEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312]. _h[electronic resource] |
| 260 |
_bBMC surgery _cAug 2005 |
||
| 300 |
_a18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlanine Transaminase _xmetabolism |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xmetabolism |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 |
_aCyclosporine _xadverse effects |
| 650 | 0 | 4 |
_aCytoprotection _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aGlycine _xadministration & dosage |
| 650 | 0 | 4 |
_aGlycine Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
| 650 | 0 | 4 |
_aKupffer Cells _xdrug effects |
| 650 | 0 | 4 |
_aLiver Transplantation _xmortality |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 | _aPostoperative Care |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aReperfusion Injury _xdiagnosis |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aUnnebrink, Kristina | |
| 700 | 1 | _aSeibert-Grafe, Monika | |
| 700 | 1 | _aBunzendahl, Hartwig | |
| 700 | 1 | _aKraus, Thomas W | |
| 700 | 1 | _aBüchler, Markus W | |
| 700 | 1 | _aKlar, Ernst | |
| 700 | 1 | _aSchemmer, Peter | |
| 773 | 0 |
_tBMC surgery _gvol. 5 _gp. 18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2482-5-18 _zAvailable from publisher's website |
| 999 |
_c15742577 _d15742577 |
||